Health centers have no remedy against pharmaceutical companies that they say are overcharging them for certain drugs because the government isn’t doing its regulatory duties, a community health-care association alleged in a lawsuit against the HHS.
The National Association of Community Health Centers wants the government to finalize a dispute resolution policy so facilities have a clear way to push back against drug companies, according to a complaint filed Wednesday in the U.S. District Court for the District of Columbia.
At the center of the lawsuit is a federal drug discount program called 340B that mandates drugmakers offer steep discounts ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.